Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany
Cat.No.
DADF-041
Product Name
2% Aluminum hydroxide adjuvant (Vaccine adjuvant)
Subclassification
Adjuvants for protein-based vaccines
Classification
Adjuvant
Storage
Shipping conditions: Room Temperature.
Storage conditions: Room Temperature.
Shelf life: 1 year from the date of purchase.
Do not freeze.
Recommended Usage
Recommendations before starting:
The inoculum should be free of extraneous microbial contamination; filtration of the antigen before mixing with the adjuvant is recommended.
Preparation of Aluminum hydroxide-immunogens mix is easier than other adjuvants as it does not require laborious emulsification.
1. Ensure complete re-suspension of Aluminum hydroxide adjuvant by vigorous shaking of the vial before use.
2. Dilute antigen mixture in saline buffer or phosphate buffer for a final immunogen concentration of 10-100 µg/100 µL.
3. Mix Aluminum hydroxide adjuvant with an equal volume of antigen solution for a 1:1 ratio:
a. Add Aluminum hydroxide dropwise with constant mixing to the immunogen solution.
b. Pipet up and down several times to ensure correct absorption of antigen by alum adjuvant and incubate 5-10 min.
NOTE: Ratio can be optimized from 1:1 (100 µL adjuvant per 100 µL antigen) to 1:9 (100 µL adjuvant per 900 µL antigen).
4. Inject into the animal according to table 1 below; the volume depends on the site of injection.
Typical routes of administration include subcutaneous (SC), intramuscular (IM), intradermal (ID) or intraperitoneal (IP)
SpeciesMax vol. / SitePrimary InjectionSubsequent Injection(s)
Mice, hamsters0.1 mLSCSC
Mice, hamsters0.05 mLIM∆IM∆
Mice0.5 mLIP×SC, IM∆
Guinea pigs, rats0.2 mLSC, IM∆SC, IM∆
Rabbits0.25 mLSC, IMSC, IM
Rabbits0.025 mLID SC,IM
Sheep, goats, donkeys,
pigs, chickens
0.5 mLSC, IM
∆ Not recommended in general, particularly for viscous adjuvants.
× Not recommended for pAb production.
Table 1: Maximum volumes for injection of immunogen/adjuvant
mixtures per site of injection for different animal species.
Description
Aluminum hydroxide is the most common adjuvant used in approved prophylactic vaccines because of its excellent safety profile and ability to enhance protective humoral immune response. Since more than 80 years, it has been observed that aluminum compounds act by a depot effect and by direct activation of the immune cells. Adsorption or entrapment of antigens in aggregates through hydrophobic and electrostatic interactions favors a high local antigen concentration and improved uptake by Antigen Presenting Cells (APC).
Aluminum hydroxide stimulates Th2 response through the release of Th2-associated cytokines (IL4, IL-5, IL-13…) and Th2-associated antibodies (IgG1 & IgE). It increases Ag-specific CD4+ T Cell proliferation and promotes NALP3 inflammasome activation and caspase 1-mediated release of IL-1 and IL-18.
NOTE: Alum is frequently used as an alternative to Freund's adjuvants, as it is less hazardous and less likely to cause tissue necrosis at the injection site.
Format
Al(OH)3, Aluminum hydroxide gel
Appearance
White gelatinous precipitate
Aluminium content
9.0 – 11.0 mg/ml; pH: ~6.5
CAS
21645-51-2
Online Inquiry
Inquiry Basket
loading Loading ......

Inquiry

Inquiry